What is the Purpose of this Study?
Not Available
Eligibility
- * Adult participants ≥ 18 years old at the time of signing the informed consent form.
- * Patients hospitalised with viral lung infection.
- * Hypoxaemia requiring treatment with supplemental O2.
Where can I participate?
Torrance Memorial Medical Center (CSMC Affiliate)
More about this Clinical Trial
What is the full name of this clinical trial?
TMMC- TILIA A Phase III, Multicentre, Randomized, Double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of Tozorakimab in patients hospitalised for viral lung infection requiring supplemental oxygen